These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3742657)

  • 1. Regional distribution and elimination kinetics of imipramine in rat brain after a single intraperitoneal administration.
    Masada M; Suzuki K; Kikuta S; Yamashita S; Nakanishi K; Nadai T; Igarashi Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1986 May; 34(5):2173-7. PubMed ID: 3742657
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional distribution and elimination kinetics of imipramine in rat brain after multiple dosages.
    Masada M; Suzuki K; Kikuta S; Yamashita S; Nakanishi K; Nadai T; Igarashi Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):927-30. PubMed ID: 3708738
    [No Abstract]   [Full Text] [Related]  

  • 3. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of imipramine, desipramine and specific [3H]desipramine binding sites in the rat brain after acute and chronic treatment with imipramine.
    Daniel W; Danek L; Janczar L; Nocon H; Melzacka M
    J Pharm Pharmacol; 1991 Jan; 43(1):31-5. PubMed ID: 1676056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution and elimination kinetics of imipramine in rat brain.
    Masada M; Suzuki K; Kikuta S; Yamashita S; Nakanishi K; Nadai T; Igarashi Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4678-81. PubMed ID: 6532564
    [No Abstract]   [Full Text] [Related]  

  • 6. The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.
    Daniel W; Adamus A; Melzacka M; Szymura J
    J Pharm Pharmacol; 1982 Oct; 34(10):678-80. PubMed ID: 6128396
    [No Abstract]   [Full Text] [Related]  

  • 7. On the metabolism of imipramine (Tofanil) in rat brain after single or repeated injections.
    Schneider G; Schneider G
    Ger Med Mon; 1968 Nov; 13(11):543-4. PubMed ID: 5720270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Appearance of desmethylimipramine in rat brain following administration of imipramine as a function of the injection technic].
    Schneider G; Bickel MH
    Psychopharmacologia; 1969; 16(2):156-60. PubMed ID: 5363131
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation and biliary excretion of imipramine in rats under various experimental conditions.
    Gigon PL
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):315-27. PubMed ID: 1180619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adrenalectomy and corticosterone on [3H]imipramine binding in rat blood platelets and brain.
    Arora RC; Meltzer HY
    Eur J Pharmacol; 1986 Apr; 123(3):415-9. PubMed ID: 3720826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of imipramine binding sites in the rat brain studied by quantitative autoradiography.
    Biegon A; Rainbow TC
    Neurosci Lett; 1983 Jun; 37(3):209-14. PubMed ID: 6310447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of imipramine-N-oxide in rats.
    Nagy A
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):68-72. PubMed ID: 579713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI; Suckow RF; Cooper TB
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional distribution of [3H]imipramine binding in rat brain.
    Palkovits M; Raisman R; Briley M; Langer SZ
    Brain Res; 1981 Apr; 210(1-2):493-8. PubMed ID: 7225822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of chlorpromazine and imipramine in adipose and other tissues of rats.
    Bickel MH; Graber BE; Moor M
    Life Sci; 1983 Nov; 33(20):2025-31. PubMed ID: 6645788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine.
    Bickel MH; Weder HJ
    Arch Int Pharmacodyn Ther; 1968 Jun; 173(2):433-63. PubMed ID: 5684271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.